Bangladesh-based Square Pharmaceuticals has two new plants online

A Square facility--Courtesy of Telstar

Spain design and build firm Telstar says it has completed the two newest manufacturing plants for Square Pharmaceuticals, the largest drugmaker in Bangladesh. The project included a 32,000-square-meter, four-story solid-dose facility that included 11 tablet lines and four capsule lines. The second is a 20,000-square-meter, four-story building for producing parenterals to be packaged in bags, vials, prefilled syringes and lyophilized vials. Square said in June that the FDA had passed its manufacturing facilities in a preproduction audit. Release | More

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.